CCL5 expression has also been correlated with breast cancer poor prognosis [78], lymph node metastasis [78], residual tumor size, and tumor infiltration of lymphocytes after neoadjuvant chemotherapy [80]. The gene discussed is CCL5; the disease is metastatic malignant neoplasm in the lymph nodes.